三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
中国双抗申报数量(按主要TAA分)
中国双抗申报数量(按主要TAA分)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:40KB
图片尺寸:1093*980
同报告图片
/
4
fCDpobnnm64gICAgICAgfCDmlbDph48gfAp8LS0tLS0tLS0tLS0tfC0tLS0tLXwKfCBIRVIyICAgICAgIHwgMTAgICB8CnwgRUdGUiAgICAgICB8IDggICAgfAp8IENEMjAgICAgICAgfCA3ICAgIHwKfCBDbGF1ZGluIDE4LjIgfCA2ICAgIHwKfCBWRUdGICAgICAgIHwgNiAgICB8CnwgQkNNQSAgICAgICB8IDUgICAgfAoK6LWE5paZ5p2l5rqQ77yaQ0RF44CB5rWm6ZO25Zu96ZmF
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yM5bm25Zyo6KGo5qC85LiL5pa55bGV56S65LqG6LWE5paZ5p2l5rqQ77yaCgp8IFBELTEgICAgICAgfCDlrqLop4LnvJPop6PnjofvvIg5NSVDSe+8iSB8IOWujOWFqOe8k+ino+eOhyB8IDEy5Liq5pyI5oyB57ut5bqU562U546H77yIOTUlQ0nvvIkgfCA25Liq5pyI5peg6L+b5bGV55Sf5a2Y546H77yIOTUlQ0nvvIkgfCAxMuS4quaciOaXoOi/m+WxleeUn+WtmOeOh++8iDk1JUNJ77yJIHwgM+e6p+S7peS4ilRSQUUgfCDmsrvnlpfnm7jlhbNTQUUgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLXwKfCDmtL7lronmma7liKnljZXmipcgfCA4OS40Je+8iDgwLjglLCA5NSXvvIkgIHwgNDguMjAlICAgICB8IDg4Ljgl77yINzguOSUsIDk0LjIl77yJICAgIHwgODcuOCXvvIg3OC41JSwgOTMuMyXvvIkgICAgfCA3Mi4xJe+8iDYwLjUlLCA4MC44Je+8iSAgICB8IDE5LjEwJSAgICAgIHwgOC41MCUgICAgICAgfAp8IOS/oei/quWIqeWNleaKlyAgfCA3OC43Je+8iDY3LjclLCA4Ny4zJe+8iXwgMjguMDAlICAgICB8IDgyLjQl77yINzMlLCA5MS44Je+8iSAgICAgIHwgODEuMSXvvIg3Mi4yJSwgOTAl77yJICAgICAgfCA2Mi43Je+8iDUwLjUlLCA3NC45Je+8iSAgICB8IDMzLjMwJSAgICAgIHwgMjEuOTAlICAgICAgfAp8IOWNoeeRnuWIqeePoOWNleaKl3wgNzcuMyXvvIg2NS4zJSwgODYuNyXvvIl8IDMxLjgwJSAgICAgfCA4NS45Je+8iDcyLjYlLCA5MyXvvIkgICAgICB8IDg0LjYl77yINzMuMiUsIDkxLjQl77yJICAgIHwgNjguMSXvvIg1NC40JSw3OC40Je+8iSAgICAgfCAyNi43MCUgICAgICB8IDEyLjAwJSAgICAgIHwKfCDmm7/pm7fliKnnj6DljZXmipd8IDc2Ljkl77yINjQuOCUsIDg2LjUl77yJfCA2MS41MCUgICAgIHwgODcl77yINzMuMyUsIDkzLjkl77yJICAgICAgfCA4MC42Je+8iDY4LjQlLCA4OC41Je+8iSAgICB8IDcxLjYl77yINTguMiUsIDgxLjQl77yJICAgIHwgICAgICAgICAgICAgfCAgICAgICAgICAgICB8Cnwg5biV5Y2a5Yip54+g5Y2V5oqXfCA3MS45Je+8iDY1LjMlLCA3Ny45Je+8iXwgMjcuNjAlICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICB8ICAgICAgICAgICAgIHwgICAgICAgICAgICAgfAp8IOe6s+atpuWIqeWwpOWNleaKl3wgNjkl77yINjMlLCA3NSXvvIkgICAgICB8IDE0LjAwJSAgICAgfCAgICAgICAgICAgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICB8ICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOi1hOaWmeOAgea1pumTtuWbvemZhQ==
所属报告:
中国肿瘤创新药行业:行业发展关键问题及公司竞争现状分析-220727(292页).pdf
打包全文图表
相关数据
国泰海通资产配置团队大类资产配置框架:“SAA+TAA+重大事件审议调整”三部曲
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
收藏
行业数据
2026-01-12
原图定位
查看详情
全球大类资产配置BL策略(TAA):年化收益率26.1%,夏普比达到1.80
收藏
行业数据
2026-01-12
原图定位
查看详情
SAA中枢+TAA增厚:2025年以来收益率达到21.7%
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
收藏
行业数据
2026-01-12
原图定位
查看详情
全球大类资产配置BL策略(TAA):2025年收益率高达59%
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
收藏
行业数据
2026-01-12
原图定位
查看详情
EVM14是一款靶向5种肿瘤相关抗原(TAA)的疫苗
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
收藏
行业数据
2025-05-26
原图定位
查看详情
图表1战略资产配置(SAA)与战术资产配置(TAA)对比
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
收藏
其它
2024-03-29
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
既然做出差异化的 PD-1/PD-L1 单抗并不容易,一些肿瘤药企布局靶向 PD-1/PD-L1 的双特异性/多特异性抗体或融合蛋白(即同一个分子既抑制 PD-1也靶向其他靶点),力图在单抗的基础上进一步提升抗癌作用。目前和 PD-1/PD-L1 搭配的靶点包括各类肿瘤相关抗原(即 TAA,如 HER2)和免疫检查点(如 CTLA-4)。我们认为,那些能在肿瘤微环境(TME)下和 PD-1/PD-L1 有协同作用、抑或整体改善 TME 的靶点(如 CTLA-4、LAG-3 等)成功概率较大。
行业数据
原图定位
当前图表所属:
中国肿瘤创新药行业:行业发展关键问题及公司竞争现状分析-220727(292页).pdf
表现金流量表
派安普利单抗vs其他PD-1临床数据:鼻咽癌、肝癌、非小细胞肺癌
各PD-1治疗复发/难治霍奇金淋巴瘤临床数据比较
派安普利单抗临床布局
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》